NFKB1 and neoplasm: Mechanistically, our data further showed that CBL0137 has tumor-suppressive effects in B-NHL cells by inhibiting the NF-κB pathway, activating the p53 pathway, and inducing chromatin trapping of FACT (Additional file 1: Fig. S1), which is the classical antitumor mechanism of CBL0137.